| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | -0.0035 | 1 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |